| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Gritstone bio, Inc. | Director | Common Stock | 0 | $47.6K | $1.90 | Apr 4, 2025 | Direct |
| Nabriva Therapeutics plc | Director | Ordinary Shares | 11.4K | $17.2K | $1.50 | Aug 2, 2022 | Direct |
| Cullinan Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 38.5K | Jun 12, 2025 | Direct | ||
| NextCure, Inc. | Director | Stock Option (Right to Buy) | 18.7K | Jun 20, 2025 | Direct | ||
| Gritstone bio, Inc. | Director | Stock Option (Right to Buy) | 0 | Apr 4, 2025 | Direct | ||
| TCR2 THERAPEUTICS INC. | Director | Stock Option (Right to Buy) | 0 | $0.74 | Jun 1, 2023 | Direct |